Published in Am J Physiol Gastrointest Liver Physiol on July 01, 2000
A prospective randomized study in 100 consecutive patients undergoing major liver resection with versus without ischemic preconditioning. Ann Surg (2003) 2.48
Activation of AMP-activated protein kinase in the liver: a new strategy for the management of metabolic hepatic disorders. J Physiol (2006) 2.47
Cardioprotection by metabolic shut-down and gradual wake-up. J Mol Cell Cardiol (2009) 1.68
A prospective, randomized, controlled trial comparing intermittent portal triad clamping versus ischemic preconditioning with continuous clamping for major liver resection. Ann Surg (2006) 1.39
The current state of knowledge of hepatic ischemia-reperfusion injury based on its study in experimental models. J Biomed Biotechnol (2012) 1.10
Molecular mechanisms of liver preconditioning. World J Gastroenterol (2010) 1.06
Hepatic ischemia-reperfusion injury: roles of Ca2+ and other intracellular mediators of impaired bile flow and hepatocyte damage. Dig Dis Sci (2006) 0.95
Effects of ischemic preconditioning on cyclinD1 expression during early ischemic reperfusion in rats. World J Gastroenterol (2006) 0.93
AMPK-associated signaling to bridge the gap between fuel metabolism and hepatocyte viability. World J Gastroenterol (2010) 0.92
The combination of ischemic preconditioning and liver Bcl-2 overexpression is a suitable strategy to prevent liver and lung damage after hepatic ischemia-reperfusion. Am J Pathol (2002) 0.88
Histochemical approach of cryobiopsy for glycogen distribution in living mouse livers under fasting and local circulation loss conditions. Histochem Cell Biol (2009) 0.85
Ischemic preconditioning confers antiapoptotic protection during major hepatectomies performed under combined inflow and outflow exclusion of the liver. A randomized clinical trial. World J Surg (2009) 0.84
Adenosine and inosine exert cytoprotective effects in an in vitro model of liver ischemia-reperfusion injury. Int J Mol Med (2012) 0.83
Conventional, but not remote ischemic preconditioning, reduces iNOS transcription in liver ischemia/reperfusion. World J Gastroenterol (2014) 0.80
Role of ischaemic preconditioning in liver regeneration following major liver resection and transplantation. World J Gastroenterol (2007) 0.77
Effect of the pringle maneuver on tumor recurrence of hepatocellular carcinoma after curative resection (EPTRH): a randomized, prospective, controlled multicenter trial. BMC Cancer (2012) 0.77
Metabolic profiling during ex vivo machine perfusion of the human liver. Sci Rep (2016) 0.77
Chronic lower extremity ischemia: a human model of ischemic tolerance. Can J Surg (2004) 0.76
Ischemic preconditioning versus intermittent vascular inflow control during major liver resection in pigs. World J Surg (2005) 0.76
Some mechanisms of the protective effect of ischemic preconditioning on rat liver ischemia-reperfusion injury. Int J Gen Med (2014) 0.76
Protective mechanisms of hypothermia in liver surgery and transplantation. Mol Med (2015) 0.75
The effect of preconditioning on liver regeneration after hepatic resection in cirrhotic rats. Korean J Hepatol (2011) 0.75
Jolkinolide B induces apoptosis and inhibits tumor growth in mouse melanoma B16F10 cells by altering glycolysis. Sci Rep (2016) 0.75
Immediately transcripted genes in various hepatic ischemia models. J Korean Surg Soc (2012) 0.75
A kinetic study of pyrophosphate: fructose-6-phosphate phosphotransferase from potato tubers. Application to a microassay of fructose 2,6-bisphosphate. Eur J Biochem (1982) 6.74
Long-term results of biopsy-guided selection and allocation of kidneys from older donors in older recipients. Am J Transplant (2012) 2.17
Hormonal control of fructose 2,6-bisphosphate concentration in isolated rat hepatocytes. Biochem J (1983) 1.64
Protective effect of preconditioning on the injury associated to hepatic ischemia-reperfusion in the rat: role of nitric oxide and adenosine. Hepatology (1997) 1.59
Riboflavin 3'- and 5'-sulfate, two novel flavins accumulating in the roots of iron-deficient sugar beet (Beta vulgaris). J Biol Chem (1993) 1.44
PFK-2/FBPase-2: maker and breaker of the essential biofactor fructose-2,6-bisphosphate. Trends Biochem Sci (2001) 1.43
Adenosine monophosphate-activated protein kinase mediates the protective effects of ischemic preconditioning on hepatic ischemia-reperfusion injury in the rat. Hepatology (2001) 1.43
Effects of adenosine on ischaemia-reperfusion injury associated with rat pancreas transplantation. Br J Surg (2001) 1.42
[Non-beating heart donors--Maastricht type III: a real option]. Med Intensiva (2010) 1.38
Serotonergic status in human blood. Life Sci (1988) 1.38
Endoplasmic reticulum stress inhibition protects steatotic and non-steatotic livers in partial hepatectomy under ischemia-reperfusion. Cell Death Dis (2010) 1.31
The stimulation of yeast phosphofructokinase by fructose 2,6-bisphosphate. FEBS Lett (1982) 1.27
Intestinal preconditioning is mediated by a transient increase in nitric oxide. Biochem Biophys Res Commun (1996) 1.21
Liver ischemic preconditioning is mediated by the inhibitory action of nitric oxide on endothelin. Biochem Biophys Res Commun (1996) 1.19
A zinc-finger transcription factor induced by TGF-beta promotes apoptotic cell death in epithelial Mv1Lu cells. FEBS Lett (1999) 1.17
Activation of alveolar macrophages in lung injury associated with experimental acute pancreatitis is mediated by the liver. Ann Surg (1999) 1.16
Interaction and functional cooperation of NF-kappa B with Smads. Transcriptional regulation of the junB promoter. J Biol Chem (2000) 1.15
Preconditioning protects against systemic disorders associated with hepatic ischemia-reperfusion through blockade of tumor necrosis factor-induced P-selectin up-regulation in the rat. Hepatology (2001) 1.15
Protective effect of ozone treatment on the injury associated with hepatic ischemia-reperfusion: antioxidant-prooxidant balance. Free Radic Res (1999) 1.14
Cells overexpressing fructose-2,6-bisphosphatase showed enhanced pentose phosphate pathway flux and resistance to oxidative stress. FEBS Lett (2000) 1.13
Protective effect of liver ischemic preconditioning on liver and lung injury induced by hepatic ischemia-reperfusion in the rat. Hepatology (1999) 1.12
The protective role of adenosine in inducing nitric oxide synthesis in rat liver ischemia preconditioning is mediated by activation of adenosine A2 receptors. Hepatology (1999) 1.11
JunB is involved in the inhibition of myogenic differentiation by bone morphogenetic protein-2. J Biol Chem (1998) 1.11
c-met mRNA overexpression in human hepatocellular carcinoma. Hepatology (1994) 1.11
Intrapericardial streptokinase fibrinolysis in the management of purulent pneumococcal pericarditis. Intensive Care Med (1997) 1.09
The ability of adenosine to decrease the concentration of fructose 2,6-bisphosphate in isolated hepatocytes. A cyclic AMP-mediated effect. Biochem J (1984) 1.09
Donor age and delayed graft function as predictors of renal allograft survival in rejection-free patients. Nephrol Dial Transplant (1999) 1.07
Insulin-like effects of vanadate on glucokinase activity and fructose 2,6-bisphosphate levels in the liver of diabetic rats. J Biol Chem (1988) 1.05
Murine cytomegalovirus stimulates cellular thymidylate synthase gene expression in quiescent cells and requires the enzyme for replication. J Virol (2000) 1.05
Effect of abscisic Acid on the linoleic Acid metabolism in developing maize embryos. Plant Physiol (1991) 1.04
Ischemic preconditioning: a defense mechanism against the reactive oxygen species generated after hepatic ischemia reperfusion. Transplantation (2002) 1.04
Role of P-selectin and ICAM-1 in pancreatitis-induced lung inflammation in rats: significance of oxidative stress. Ann Surg (1999) 1.02
PFKFB3 gene silencing decreases glycolysis, induces cell-cycle delay and inhibits anchorage-independent growth in HeLa cells. FEBS Lett (2006) 1.01
The response of the hepatocyte to ischemia. Liver Int (2007) 1.01
Interleukin-8 induces the accumulation of B-cell chronic lymphocytic leukemia cells by prolonging survival in an autocrine fashion. Blood (1996) 1.00
Induction of the Sry-related factor SOX6 contributes to bone morphogenetic protein-2-induced chondroblastic differentiation of C3H10T1/2 cells. Mol Endocrinol (2003) 0.99
Purification and characterization of phosphoglycerate mutase isozymes from pig heart. Biochim Biophys Acta (1982) 0.99
Release of peptide leukotriene into nasal secretions after local instillation of aspirin in aspirin-sensitive asthmatic patients. Am Rev Respir Dis (1992) 0.98
Free radical enhancement promotes leucocyte recruitment through a PAF and LTB4 dependent mechanism. Free Radic Biol Med (1997) 0.98
Protective effect of ischemic preconditioning on cold preservation and reperfusion injury associated with rat intestinal transplantation. Ann Surg (2001) 0.97
Leukotriene generation and neutrophil infiltration after experimental acute pancreatitis. Inflammation (1998) 0.97
Hepatic preconditioning in rats is defined by a balance of adenosine and xanthine. Hepatology (1998) 0.96
Expression of an altered ribonucleotide reductase activity associated with the replication of murine cytomegalovirus in quiescent fibroblasts. J Virol (2000) 0.96
Phylogeny and ontogeny of the phosphoglycerate mutases--IV. Distribution of glycerate-2,3-P2 dependent and independent phosphoglycerate mutases in algae, fungi, plants and animals. Comp Biochem Physiol B (1982) 0.94
Free radicals generated by xanthine oxidase mediate pancreatitis-associated organ failure. Dig Dis Sci (1998) 0.94
Hepatic involvement in pancreatitis-induced lung damage. Am J Physiol (1996) 0.94
Matrix metalloproteinase 2 in reduced-size liver transplantation: beyond the matrix. Am J Transplant (2010) 0.93
IGL-1 solution reduces endoplasmic reticulum stress and apoptosis in rat liver transplantation. Cell Death Dis (2012) 0.93
The mechanism by which ethanol decreases the concentration of fructose 2,6-bisphosphate in the liver. Biochem J (1984) 0.92
P-selectin expression and Kupffer cell activation in rat acute pancreatitis. Dig Dis Sci (2000) 0.91
Cyclooxygenase and lipoxygenase arachidonic acid metabolism by monocytes from human immune deficiency virus-infected drug users. J Chromatogr (1991) 0.91
Inhibition of phosphoglucomutase by fructose 2,6-bisphosphate. Biochim Biophys Acta (1985) 0.90
Liver ischemic preconditioning: a new strategy for the prevention of ischemia-reperfusion injury. Transplant Proc (2003) 0.89
P-selectin upregulation in bleomycin induced lung injury in rats: effect of N-acetyl-L-cysteine. Thorax (2002) 0.89
Modification of oxidative stress in response to intestinal preconditioning. Transplantation (2000) 0.89
Detection of Haemophilus influenzae type b antigenuria by Bactigen and Phadebact kits. J Clin Microbiol (1985) 0.89
Chronic myeloid leukemia cells resistant to interferon-alpha lack STAT1 expression. Hematol J (2000) 0.88
Effect of vanadate on phosphoryl transfer enzymes involved in glucose metabolism. Biochem Biophys Res Commun (1981) 0.88
Effect of ozone treatment on reactive oxygen species and adenosine production during hepatic ischemia-reperfusion. Free Radic Res (2000) 0.88
JAK2V617F activating mutation is associated with the myeloproliferative type of chronic myelomonocytic leukaemia. J Clin Pathol (2009) 0.87
Effects of fructose 2,6-bisphosphate on phosphoglucomutase from plants. Plant Physiol (1986) 0.87
Vanadate inhibits 2,3-bisphosphoglycerate dependent phosphoglycerate mutases but does not affect the 2,3-bisphosphoglycerate independent phosphoglycerate mutases. Biochem Biophys Res Commun (1980) 0.87
Role of ischemic preconditioning and the portosystemic shunt in the prevention of liver and lung damage after rat liver transplantation. Transplantation (2003) 0.87
Transcriptional and posttranscriptional regulation of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase during liver regeneration. Proc Natl Acad Sci U S A (1992) 0.87
How ischaemic preconditioning protects small liver grafts. J Pathol (2006) 0.87